Clinical trial
Study of the Bioavailability of Hesperidine and Narirutin Provided by an Orange Juice to Identify Various Metabotypes in Prehypertensive and Hypertensive Grade 1 Individuals (FLAVOTIP)
NCT04234100 is registered in ClinicalTrials.gov with Technological Centre of Nutrition and Health, Spain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Bioavailability of Hesperidine and Narirutin Provided by an Orange Juice to Identify Various Metabotypes in Prehypertensive and Hypertensive Grade 1 Individuals (FLAVOTIP)
- Lead sponsor
- Technological Centre of Nutrition and Health, Spain
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 24, 2020
- Completion date
- September 22, 2020
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure, hypertension